Our Solution

BRING BACK SPONTANEITY

LTR Pharma Couple

RAPID ONSET ACTION

PDE5 INHIBITION

SPONTAN®
FASTER IS BETTER

  • Intranasal delivery technology of safe and effective oral PDE5 inhibitor, Vardenafil HCL
  • Enhanced trans mucosal absorption
  • Increased bioavailability and lower drug dose
  • Faster onset of action
  • Target clinical indication – erectile dysfunction (ED)
  • Unique manufacturing process specific to Vardenafil
  • POC validated
  • IP Protected

IN DELIVERY
Key Advantages of Intranasal (IN) Delivery

  • Non-invasive
  • Bypasses the Liver and 1st pass metabolism
  • Large highly vascular surface
    improves bioavailability
  • Provides therapeutic effect at lower dose
  • Provides faster onset of action
  • Reduces the risk of systemic exposure and side effects
  • More convenient for certain patient
    groups such as those with dysphagia 

Therapeutic effects at lower doses

Learn More

Watch this short animation to learn more about the potential mechanism of action of SPONTAN® – and the science behind its design.

LTR Pharma Happy Man Crop

ON DEMAND SOLUTION

LTR Pharma is commercialising a ‘First in Class’ rapid treatment for Erectile Dysfunction (ED) - SPONTAN®

Receive our latest news and investor updates

By entering your email address you are agreeing to our privacy policy.